|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Arnold M, Sierra MS, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global patterns and trends in
colorectal cancer incidence and mortality. Gut. 66:683–691. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yin J, Bai Z, Zhang J, Zheng Z, Yao H, Ye
P, Li J, Gao X and Zhang Z: Burden of colorectal cancer in China,
1990–2017: Findings from the Global Burden of disease study 2017.
Chin J Cancer Res. 31:489–498. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Clough E and Barrett T: The gene
expression omnibus database. Methods Mol Biol. 1418:93–110. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Monticone M, Panfoli I, Ravera S, Puglisi
R, Jiang MM, Morello R, Candiani S, Tonachini L, Biticchi R,
Fabiano A, et al: The nuclear genes Mtfr1 and Dufd1 regulate
mitochondrial dynamic and cellular respiration. J Cell Physiol.
225:767–776. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang J, Xie Y, Bai X, Wang N, Yu H, Deng
Z, Lian M, Yu S, Liu H, Xie W and Wang M: Targeting dual
specificity protein kinase TTK attenuates tumorigenesis of
glioblastoma. Oncotarget. 9:3081–3088. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang W, Xiong M, Jiang L, Chen Z and Shao
Y: MTFR2 promotes the proliferation, migration, and invasion of
oral squamous carcinoma by switching OXPHOS to glycolysis. Front
Oncol. 10:8582020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lu W, Zang R, Du Y, Li X, Li H, Liu C,
Song Y, Li Y and Wang Y: Overexpression of MTFR2 predicts poor
prognosis of breast cancer. Cancer Manag Res. 12:11095–11102. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lu G, Lai Y, Wang T, Lin W, Lu J, Ma Y,
Chen Y, Ma H, Liu R and Li J: Mitochondrial fission regulator 2
(MTFR2) promotes growth, migration, invasion and tumour progression
in breast cancer cells. Aging (Albany NY). 11:10203–10219. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Enteghami M, Ghorbani M, Zamani M and
Galehdari H: HOXC10 is significantly overexpressed in colorectal
cancer. Biomed Rep. 13:182020.PubMed/NCBI
|
|
11
|
Peng Y, Li Y, Li Y, Wu A, Fan L, Huang W,
Fu C, Deng Z, Wang K, Zhang Y, et al: HOXC10 promotes tumour
metastasis by regulating the EMT-related gene Slug in ovarian
cancer. Aging (Albany NY). 12:19375–19398. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li J, Tong G, Huang C, Luo Y, Wang S,
Zhang Y, Cheng B, Zhang Z, Wu X, Liu Q, et al: HOXC10 promotes cell
migration, invasion, and tumor growth in gastric carcinoma cells
through upregulating proinflammatory cytokines. J Cell Physiol.
235:3579–3591. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Guan Y, He Y, Lv S, Hou X, Li L and Song
J: Overexpression of HOXC10 promotes glioblastoma cell progression
to a poor prognosis via the PI3K/AKT signalling pathway. J Drug
Target. 27:60–66. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liang PS and Shaukat A: Assessing the
impact of lowering the colorectal cancer screening age to 45 years.
Lancet Gastroenterol Hepatol. 5:523–524. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Song WY, Zhang X, Zhang Q, Zhang PJ and
Zhang R: Clinical value evaluation of serum markers for early
diagnosis of colorectal cancer. World J Gastrointest Oncol.
12:219–227. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang K, Xu H and Li HT: Safety and
efficacy of propofol alone or in combination with other agents for
sedation of patients undergoing colonoscopy: An updated
meta-analysis. Eur Rev Med Pharmacol Sci. 24:4506–4518.
2020.PubMed/NCBI
|
|
18
|
Park SW, Shin SP and Hong JT: Efficacy and
tolerability of prucalopride in bowel preparation for colonoscopy:
A systematic review and Meta-analysis. Adv Ther. 37:2507–2519.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lima AR, Santos L, Correia M, Soares P,
Sobrinho-Simões M, Melo M and Máximo V: Dynamin-related protein 1
at the crossroads of cancer. Genes (Basel). 9:1152018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sheridan C and Martin SJ: Mitochondrial
fission/fusion dynamics and apoptosis. Mitochondrion. 10:640–648.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu D, Duan W, Guo H, Xu X and Bai Y:
Meta-analysis of associations between polymorphisms in the promoter
regions of matrix metalloproteinases and the risk of colorectal
cancer. Int J Colorectal Dis. 26:1099–1105. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dong W, Li H, Zhang Y, Yang H, Guo M, Li L
and Liu T: Matrix metalloproteinase 2 promotes cell growth and
invasion in colorectal cancer. Acta Biochim Biophys Sin (Shanghai).
43:840–848. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Morán A, Iniesta P, García-Aranda C, De
Juan C, Díaz-López A, Sánchez-Pernaute A, Torres AJ, Díaz-Rubio E,
Balibrea JL and Benito M: Clinical relevance of MMP-9, MMP-2,
TIMP-1 and TIMP-2 in colorectal cancer. Oncol Rep. 13:115–120.
2005.PubMed/NCBI
|
|
24
|
McGinnis W and Krumlauf R: Homeobox genes
and axial patterning. Cell. 68:283–302. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhai Y, Kuick R, Nan B, Ota I, Weiss SJ,
Trimble CL, Fearon ER and Cho KR: Gene expression analysis of
preinvasive and invasive cervical squamous cell carcinomas
identifies HOXC10 as a key mediator of invasion. Cancer Res.
67:10163–10172. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Feng X, Li T, Liu Z, Shi Y and Peng Y:
HOXC10 up-regulation contributes to human thyroid cancer and
indicates poor survival outcome. Mol Biosyst. 11:2946–2954. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tang XL, Ding BX, Hua Y, Chen H, Wu T,
Chen ZQ and Yuan CH: HOXC10 promotes the metastasis of human lung
adenocarcinoma and indicates poor survival outcome. Front Physiol.
8:5572017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li S, Zhang W, Wu C, Gao H, Yu J, Wang X,
Li B, Jun Z, Zhang W, Zhou P, et al: HOXC10 promotes proliferation
and invasion and induces immunosuppressive gene expression in
glioma. FEBS J. 285:2278–2291. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zheng J, Ge P, Liu X, Wei J, Wu G and Li
X: miR-136 inhibits gastric cancer-specific peritoneal metastasis
by targeting HOXC10. Tumour Biol. 39:10104283177062072017.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Suo D, Wang Z, Li L, Chen Q, Zeng T, Liu
R, Yun J, Guan XY and Li Y: HOXC10 upregulation confers resistance
to chemoradiotherapy in ESCC tumor cells and predicts poor
prognosis. Oncogene. 39:5441–5454. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yu J, Zhang X, Ma Y, Li Z, Tao R, Chen W,
Xiong S and Han X: miR-129-5p restrains apatinib resistance in
human gastric cancer cells via downregulating HOXC10. Cancer
Biother Radiopharm. 36:95–105. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jin M and Frankel WL: Lymph node
metastasis in colorectal cancer. Surg Oncol Clin N Am. 27:401–412.
2018. View Article : Google Scholar : PubMed/NCBI
|
